(Q71123738)
Statements
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group (English)
L D Kramer
G W Pledger
E Faught
B J Wilder
R E Ramsay